Danielle S. Wallace

Hematology

601 Elmwood Ave
Rochester, NY 14642

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Sun Sets on Rituximab/Gemcitabine/Oxaliplatin as Bispecific Antibodies Rise: The SUNMO Trial.

Sun Sets on Rituximab/Gemcitabine/Oxaliplatin as Bispecific Antibodies Rise: The SUNMO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 17, 2025

Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty.

Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty.

Journal: Journal of geriatric oncology

Published: October 31, 2025

Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study.

Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study.

Journal: Blood advances

Published: September 17, 2025

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.

Journal: Blood advances

Published: September 17, 2025

Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study.

Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study.

Journal: Journal of adolescent and young adult oncology

Published: September 03, 2025

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Journal: Blood

Published: September 02, 2025

Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.

Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.

Journal: Leukemia & lymphoma

Published: August 06, 2025

Clinicopathologic Findings in T-Cell Large Granular Lymphocytic Leukemia-Associated Gamma Heavy Chain Disease.

Clinicopathologic Findings in T-Cell Large Granular Lymphocytic Leukemia-Associated Gamma Heavy Chain Disease.

Journal: International journal of surgical pathology

Published: July 04, 2025

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 26, 2025

Ready, AIM, stop: ibrutinib plus venetoclax in MCL.

Ready, AIM, stop: ibrutinib plus venetoclax in MCL.

Journal: Blood

Published: August 22, 2024

How I treat older patients with relapsed/refractory diffuse large B-cell lymphoma.

How I treat older patients with relapsed/refractory diffuse large B-cell lymphoma.

Journal: Blood

Published: June 28, 2024

Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?

Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?

Journal: EJHaem

Published: February 19, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026